Rajesh K. Malik

2018

In 2018, Rajesh K. Malik earned a total compensation of $1.3M as Chief Medical Officer and Senior Vice President Research and Development at G1 Therapeutics, a 153% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$169,400
Option Awards$696,968
Salary$400,000
Other$8,250
Total$1,274,618

Malik received $697K in option awards, accounting for 55% of the total pay in 2018.

Malik also received $169.4K in non-equity incentive plan, $400K in salary and $8.3K in other compensation.

Rankings

In 2018, Rajesh K. Malik's compensation ranked 7,983rd out of 14,244 executives tracked by ExecPay. In other words, Malik earned more than 44.0% of executives.

ClassificationRankingPercentile
All
7,983
out of 14,244
44th
Division
Manufacturing
3,140
out of 5,762
46th
Major group
Chemicals And Allied Products
1,172
out of 2,125
45th
Industry group
Drugs
984
out of 1,814
46th
Industry
Pharmaceutical Preparations
764
out of 1,388
45th
Source: SEC filing on April 24, 2020.

Malik's colleagues

We found five more compensation records of executives who worked with Rajesh K. Malik at G1 Therapeutics in 2018.

2018

John Demaree

G1 Therapeutics

Chief Commercial Officer

2018

James Hanson

G1 Therapeutics

General Counsel

2018

Terry Murdock

G1 Therapeutics

Chief Operating Officer

2018

Mark Velleca

G1 Therapeutics

Chief Executive Officer

2018

Barclay Phillips

G1 Therapeutics

Chief Financial Officer

News

In-depth

You may also like